Flurandrenolide Tape
NDC Package 17518-587-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Flurandrenolide tapes is a medication used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). This formulation utilizes a tape delivery system. Marketed by Solventum Us Llc, this product is identified by NDC 17518-587.

Identification & Billing

NDC Package Code
17518-587-24
Package Description
450 cm2 in 1 CARTON
Product Code
17518-587
11-Digit Billing Format
17518058724

Clinical Specifications

Proprietary Name
Flurandrenolide
Non-Proprietary Name
Flurandrenolide
Substance Name
Flurandrenolide
Dosage Form
Tape - A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides.
Active Ingredient(s)
FLURANDRENOLIDE 4 ug/cm2
Usage Information
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Flurandrenolide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium-strength corticosteroid. The tape acts to protect the treated skin and makes the medication more effective and longer-lasting.

Regulatory & Marketing

Labeler Name
Solventum Us Llc
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
08-15-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17518-587-24 identifies a specific commercial package of 450 cm2 in 1 carton of Flurandrenolide (UNFINISHED drug), drug for further processing labeled by Solventum Us Llc. This tape is formulated for use and contains flurandrenolide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Solventum Us Llc on August 15, 2016. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Flurandrenolide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium-strength corticosteroid. The tape acts to protect the treated skin and makes the medication more effective and longer-lasting.

How is this Solventum Us Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17518058724. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
17518-587-24
11-Digit CMS (5-4-2)
17518-0587-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.